Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer

NCT02128243 is registered in ClinicalTrials.gov with AIO-Studien-gGmbH as lead sponsor.

NCT NCT02128243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02128243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
Lead sponsor
AIO-Studien-gGmbH
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
October 8, 2020
Enrollment
242 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal adenocarcinoma, esophageal neoplasms, gastric adenocarcinoma, gastric neoplasm, gastroesophageal junction adenocarcinoma, unresectable, locally advanced or metastatic, adenocarcinoma of the stomach, or of the gastro esophageal junction